BEUDAMED
    FDA Adverse Event Injury Summary report: N

    RENESSA RF SYSTEM

    MDR report key: 1569931 · Received December 24, 2009

    Report

    Report Number
    3003647794-2009-00068
    Event Type
    Injury
    Date Received
    December 24, 2009
    Date of Event
    December 1, 2008
    Report Date
    December 1, 2009
    Manufacturer
    NOVASYS MEDICAL
    Product Code
    NVJ
    PMA / PMN Number
    K042132
    Adverse Event
    Yes
    Report Source
    Manufacturer report
    Reporter Location
    OH, US
    Reporter Occupation
    PHYSICIAN

    Narratives

    Additional Manufacturer Narrative · 1

    NO DEVICE MALFUNCTION OCCURRED. WORSENING INCONTINENCE IS A KNOWN RISK FOLLOWING ANY ANTI-INCONTINENCE PROCEDURE. FOLLOWING RENESSA, SOME PTS HAVE EXPERIENCED A WORSENING OF INCONTINENCE 3-4 WEEKS FOLLOWING THE TREATMENT AT THE TIME THAT THE URETHRAL SUBMUCOSAL TISSUE IS UNDERGOING COLLAGEN REMODELING FOLLOWING URETHRAL SUBMUCOSAL COLLAGEN DENATURATION DURING THE TREATMENT. SYMPTOMS CAN INCLUDE URINARY TRACT INFECTION, OVERFLOW URINARY INCONTINENCE, OVERACTIVE BLADDER, OR INTRINSIC SPHINCTER DEFICIENCY. ALL OF THESE CONDITIONS ARE TREATABLE. THE MANUFACTURER HAS EVALUATED DEVICES ON AN ONGOING BASIS TO DETERMINE IF ANY DEVICE RELATED MALFUNCTION MAY HAVE CONTRIBUTED TO THE OCCURRENCE OF THIS KNOWN ADVERSE EVENT. TO DATE, NO DEVICE MALFUNCTION HAS BEEN FOUND TO CONTRIBUTE TO THE EVENT, BUT INVESTIGATIONS CONTINUE. THE MANUFACTURER HAS CREATED PROCEDURAL AIDS TO EMPHASIZE APPROPRIATE PT SELECTION, HAS SIMPLIFIED THE STEPS OF THE PROCEDURE, MADE CHANGES TO THE INSTRUCTIONS FOR USE, AND HAS MADE MINOR DEVICE CHANGES TO FACILITATE EASE OF USE BY THE PHYSICIAN. THE MANUFACTURER CONTINUES TO EVALUATE THE EFFECTIVENESS OF THESE STEPS TO MINIMIZE THE OCCURRENCE OF THIS SIDE EFFECT. THE MANUFACTURER IS SUBMITTING THIS REPORT RETROSPECTIVELY FOLLOWING A REVIEW OF COMPLAINTS AFTER ESTABLISHING THAT THIS EVENT SHOULD BE MDR REPORTABLE.

    Description of Event or Problem · 1

    PT BEGAN TO HAVE WORSENING INCONTINENCE REQUIRING CONSTANT CHANGING OF PADS 4-5 WEEKS AFTER THE PROCEDURE. THE PT UNDERWENT A MIDURETHRAL SLING WITH IMPROVEMENT.

    Devices

    Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
    1 RENESSA RF SYSTEM NVJ NOVASYS MEDICAL PR0918

    Patients

    Seq Age Sex Outcome Treatment
    1 Required Intervention RENESSA RF GENERATOR